Cover Image

New Delhi metallo-beta-lactamase facilitates the emergence of cefiderocol resistance in Enterobacter cloacae

Cefiderocol is a promising novel siderophore cephalosporin for the treatment of multidrug-resistant Gram-negative bacilli and with stability against degradation by metallo-β-lactamases. Nonetheless, the emergence of cefiderocol in metallo-β-lactamase-producing Enterobacterales during therapy has bee...

Full description

Saved in:
Bibliographic Details
Main Authors: Nurjadi, Dennis (Author) , Kocer, Kaan (Author) , Chanthalangsy, Quan (Author) , Klein, Sabrina (Author) , Heeg, Klaus (Author) , Boutin, Sébastien (Author)
Format: Article (Journal)
Language:English
Published: 15 February 2022
In: Antimicrobial agents and chemotherapy
Year: 2022, Volume: 66, Issue: 2, Pages: 1-11
ISSN:1098-6596
DOI:10.1128/aac.02011-21
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1128/aac.02011-21
Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846454/
Get full text
Author Notes:Dennis Nurjadi, Kaan Kocer, Quan Chanthalangsy, Sabrina Klein, Klaus Heeg, Sébastien Boutin
Description
Summary:Cefiderocol is a promising novel siderophore cephalosporin for the treatment of multidrug-resistant Gram-negative bacilli and with stability against degradation by metallo-β-lactamases. Nonetheless, the emergence of cefiderocol in metallo-β-lactamase-producing Enterobacterales during therapy has been reported on more than one occasion. To understand the underlying mechanisms and factors facilitating the resistance development, we conducted an in vitro evolution experiment using clinical E. cloacae isolates via serial passaging under cefiderocol pressure. In this study, we showed that the presence of the New Delhi metallo-β-lactamase (NDM) facilitates the emergence of resistance via nonsynonymous mutations of the CirA catecholate siderophore receptor. Inhibition of metallo-β-lactamase activity using dipicolinic acid prevented the emergence of cefiderocol-resistant mutants successfully. This finding implies that caution should be taken when using cefiderocol for the treatment of infections caused by metallo-β-lactamase-producing bacteria.
Item Description:Gesehen am 11.05.2022
Physical Description:Online Resource
ISSN:1098-6596
DOI:10.1128/aac.02011-21

Similar Items